97628473 - VERIPURE

Information

  • Trademark
  • 97628473
  • Serial Number
    97628473
  • Filing Date
    October 12, 2022
    2 years ago
  • Transaction Date
    August 12, 2024
    3 months ago
  • Status Date
    August 12, 2024
    3 months ago
  • Location Date
    August 12, 2024
    3 months ago
  • Status Code
    654
  • Current Location
    TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    MURRAY, DAVID T
  • Attorney Docket Number
    506634-244
    Attorney Name
    Daan G. Erikson
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4
Mark Identification
VERIPURE
Case File Statements
  • GS0051: Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of tumors; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of solid tumors, namely, melanoma, breast cancer, basal cell carcinoma, prostate cancer, and small cell and non-small cell lung cancer, squamous cell carcinoma and primary and metastatic liver cancers; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of pediatric solid tumors, namely, Ewing sarcoma, neuroblastoma, osteosarcoma, neuroepithelioma, and rhabdomyosarcoma; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of leukemia; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of leukemia, namely, acute B-cell lymphoblastic leukemia, T-cell lymphoblastic leukemia, acute myeloid leukemia; Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of psoriasis; Preparations for pharmaceutical skin care; Diagnostic preparations for medical use, namely, for use in virology, microbiology, ophthalmology; Diagnostic mediums for use in virology, microbiology, ophthalmology; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators
  • GS0011: diagnostic reagents for in virology, microbiology and ophthalmology
Case File Event Statements
  • 10/15/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/17/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/27/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/27/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/27/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/27/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/12/2024 - 3 months ago
    13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 2/14/2024 - 9 months ago
    12 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 8/17/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/17/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/17/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/17/2023 - a year ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/17/2023 - a year ago
    11 - CORRESPONDENCE E-MAILED Type: GRML